皮质类固醇诱导的情绪变化在全身性自身免疫性疾病:一个多中心研究.
Mohammed Mahmoud Hamouda1, Mohammed Abdel-Hassib2, Hossam Shabana2,3
1Department of Psychiatry, Faculty of Medicine, Al-Azhar University, Cairo, Egypt.
Przeglad gastroenterologiczny
|December 31, 2025
概括
皮质类固醇治疗显著增加患者的抑郁风险和严重程度. 这项研究发现,26%的患者在治疗后患有抑郁症,这突显了皮质类固醇和心理健康结果之间的关键联系.
科学领域:
- 临床医学 临床医学
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 重度抑郁症 (MDD) 是一个日益严重的全球健康问题,特别影响年轻人.
- 以前的研究表明,皮质类固醇使用与抑郁症状的出现之间存在相关性.
研究的目的:
- 为了调查皮质类固醇治疗后抑郁症的患病率和严重程度.
- 评估皮质类固醇对患者队列心理健康的影响.
主要方法:
- 一项涉及500名接受皮质类固醇治疗的患者的横截面研究.
- 利用贝克抑郁症库存评估治疗前后的抑郁症.
- 监测各种生理标志物,包括BMI,C反应蛋白和血压.
主要成果:
- 皮质类固醇治疗后,抑郁症的患病率显著增加,26%的患者患有抑郁症.
- 平均贝克抑郁 inventory 评分从 6.02 增加到 11.28 (p < 0.001).
- 在BMI,C反应蛋白,HbA1c,血清和静脉血压 (p < 0.001) 中发现了显著的变化.
结论:
- 皮质类固醇治疗与抑郁症的存在和严重程度显著增加有关.
- 这些发现强调了在接受皮质类固醇治疗的患者中监测心理健康的重要性.
相关概念视频
Autoimmune Disorders
1.4K
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
1.4K
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
405
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
405
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
454
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
454
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
1.5K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.5K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
437
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
437
Inflammatory Bowel Disease IV: Pharmacological Management
439
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
439


